Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;59(3):629-641.
doi: 10.1007/s43441-025-00748-4. Epub 2025 Mar 18.

Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE Generation

Affiliations

Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE Generation

Nicolle M Gatto et al. Ther Innov Regul Sci. 2025 May.

Abstract

In response to the COVID-19 pandemic, a collaborative public-private partnership was launched to harness evidence from rapidly accruing real-world data (RWD) in various healthcare settings, with the goal of characterizing and understanding COVID-19 in near real-time, by applying rigorous epidemiological methods and defining research best practices. Projects were conducted in 4 phases: Research Planning and Prioritization, Protocol Development, Protocol Implementation, and Results Dissemination. During these projects, areas were identified with a current or future need to enhance existing best practices. This report provides a summary of our research processes, including application of new and existing practices, along with key learnings related to the challenges of conducting research when the clinical landscape is rapidly evolving as was the case during the first year of the COVID-19 pandemic. Such processes and learnings may be helpful to the broader research community when using RWD to understand or address future public health priorities.

Keywords: COVID-19; Epidemiologic methods; Pandemic preparedness; Real-world data; Real-world evidence; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: This paper reflects the views of the authors and should not be construed to represent FDA views or policies. Dr. Gatto, Dr. Garry and Ms. Wang are employees of Aetion, Inc., with stock options. During the design, analysis, and interpretation of the research project, Ms. Roe and Ms. Zariffa were affiliated with the U.S. Food and Drug Administration. All other authors declared no competing interests for this work.

Figures

Figure 1
Figure 1
Proposed process for descriptive and comparative effectiveness studies with designated checkpoints required to proceed.

Similar articles

References

    1. Bradley MC, Perez-Vilar S, Chillarige Y, Dong D, Martinez AI, Weckstein AR, Dal Pan GJ. Systemic corticosteroid use for COVID-19 in US outpatient settings from April 2020 to August 2021. JAMA. 2022;327(20):2015–8. 10.1001/jama.2022.4877. - PMC - PubMed
    1. Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181(1):41–51. - PMC - PubMed
    1. Bramante CT, Johnson SG, Garcia V, Evans MD, Harper J, Wilkins KJ, Huling JD, Mehta H, Alexander C, Tronieri J, Hong S, Kahkoska A, Alamgir J, Koraishy F, Hartman K, Yang K, Abrahamsen T, Stürmer T, Buse JB. Diabetes medications and associations with Covid-19 outcomes in the N3C database: a national retrospective cohort study. PLoS ONE. 2022;17(11):e0271574. 10.1371/journal.pone.0271574. - PMC - PubMed
    1. Brannock MD, Chew RF, Preiss AJ, Hadley EC, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, Moffitt RA, Funk MJ, Pfaff ER, Haendel MA, Chute CG, N3C and RECOVER Consortia. Long COVID risk and Pre-COVID vaccination: an EHR-based cohort study from the RECOVER program. Medrxiv. 2022;10(06):22280795. 10.1101/2022.10.06.22280795.
    1. Wong R, Vaddavalli R, Hall MA, Patel MV, Bramante CT, Casarighi E, Johnson SG, Lingam V, Miller JD, Reusch J, Saltz M, Stürmer T, Tronieri JS, Wilkins KJ, Buse JB, Saltz J, Huling JD, Moffitt R. N3C consortium: effect of SARS-CoV-2 infection and infection severity on longer-term glycemic control and weight in people with type 2 diabetes. Diabetes Care. 2022;45(11):2709–17. 10.2337/dc22-0730. - PMC - PubMed

LinkOut - more resources